Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro activity of telithromycin against viridans group streptococci and Streptococcus bovis isolated from blood: antimicrobial susceptibility patterns in different groups of species.

Literature DB >> 15673778

In vitro activity of telithromycin against viridans group streptococci and Streptococcus bovis isolated from blood: antimicrobial susceptibility patterns in different groups of species.

Iciar Rodríguez-Avial¹, Carmen Rodríguez-Avial, Esther Culebras, Juan J Picazo.

Abstract

The in vitro activities of penicillin, erythromycin, clindamycin, and telithromycin were determined against 155 viridans group streptococci (VGS) and 18 Streptococcus bovis blood isolates. Heterogeneity in the susceptibility patterns and macrolide resistance phenotypes and genotypes in the different groups of VGS was detected. We found seven telithromycin-resistant S. bovis isolates all harboring the erm(B) gene.

Entities: Chemical Species

Mesh：

Substances：

Year: 2005 PMID： 15673778 PMCID： PMC547341 DOI： 10.1128/AAC.49.2.820-823.2005

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

21 in total

Review 1. Classification and identification of the viridans streptococci.

Authors: A L Coykendall
Journal: Clin Microbiol Rev Date: 1989-07 Impact factor: 26.132

2. Antimicrobial susceptibility of 278 streptococcal blood isolates to seven antimicrobial agents.

Authors: J Renneberg; L L Niemann; E Gutschik
Journal: J Antimicrob Chemother Date: 1997-02 Impact factor: 5.790

3. Detection of erythromycin-resistant determinants by PCR.

Authors: J Sutcliffe; T Grebe; A Tait-Kamradt; L Wondrack
Journal: Antimicrob Agents Chemother Date: 1996-11 Impact factor: 5.191

4. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes.

Authors: H Seppälä; M Skurnik; H Soini; M C Roberts; P Huovinen
Journal: Antimicrob Agents Chemother Date: 1998-02 Impact factor: 5.191

5. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from normal flora.

Authors: Helena Seppälä; Marjo Haanperä; Mohammad Al-Juhaish; Helinä Järvinen; Jari Jalava; Pentti Huovinen
Journal: J Antimicrob Chemother Date: 2003-09-12 Impact factor: 5.790

6. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea.

Authors: Young Uh; Dong Hoon Shin; In Ho Jang; Gyu Yel Hwang; Mi Kyung Lee; Kap Jun Yoon; Hyo Youl Kim
Journal: J Antimicrob Chemother Date: 2004-04-29 Impact factor: 5.790

7. High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae.

Authors: Fiona Walsh; Joanne Willcock; Sebastian Amyes
Journal: J Antimicrob Chemother Date: 2003-08-13 Impact factor: 5.790

8. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States.

Authors: G V Doern; M J Ferraro; A B Brueggemann; K L Ruoff
Journal: Antimicrob Agents Chemother Date: 1996-04 Impact factor: 5.191

9. Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis.

Authors: L J Teng; P R Hsueh; Y C Chen; S W Ho; K T Luh
Journal: J Antimicrob Chemother Date: 1998-06 Impact factor: 5.790

10. Nosocomial bloodstream infections due to viridans streptococci in haematological and non-haematological patients: species distribution and antimicrobial resistance.

Authors: Outi Lyytikäinen; Merja Rautio; Petteri Carlson; Veli-Jukka Anttila; Risto Vuento; Hannu Sarkkinen; Anja Kostiala; Marja-Liisa Väisänen; Arja Kanervo; Petri Ruutu
Journal: J Antimicrob Chemother Date: 2004-03-10 Impact factor: 5.790

6 in total

In vitro activity of telithromycin against viridans group streptococci and Streptococcus bovis isolated from blood: antimicrobial susceptibility patterns in different groups of species.

Review 1. Classification and identification of the viridans streptococci.

2. Antimicrobial susceptibility of 278 streptococcal blood isolates to seven antimicrobial agents.

3. Detection of erythromycin-resistant determinants by PCR.

4. A novel erythromycin resistance methylase gene (ermTR) in Streptococcus pyogenes.

5. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from normal flora.

6. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea.

7. High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae.

8. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States.

9. Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis.

10. Nosocomial bloodstream infections due to viridans streptococci in haematological and non-haematological patients: species distribution and antimicrobial resistance.

1. First case of Streptococcus lutetiensis bacteremia involving a clindamycin-resistant isolate carrying the lnuB gene.

Review 2. It's not easy being green: the viridans group streptococci, with a focus on pediatric clinical manifestations.

3. Prevalence of the erm(T) gene in clinical isolates of erythromycin-resistant group D Streptococcus and Enterococcus.

4. Viridans streptococci in peritoneal dialysis peritonitis: clinical courses and long-term outcomes.

5. Characteristics of Streptococcus bovis endocarditis and its differences with Streptococcus viridans endocarditis.

6. Suppurative meningoencephalitis and perineuritis caused by Streptococcus gallolyticus in a Japanese Black calf.